CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
eWrapper-Engagement strategies to facilitate alcohol biosensor wearingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05431855
NCT05431855N/ACompleted
CompareCT.gov

Self-management of HIV and Alcohol Reaching Emerging Adults: Project Engage

Florida State University·interventional·Posted Jun 24, 2022·Updated Mar 5, 2026

In Brief

A clinical study evaluating eWrapper-Engagement strategies to facilitate alcohol biosensor wearing for HIV. Completed, enrolled 66 participants across 3 sites.

Detailed Summary

In this study, participants will be asked to wear a wrist alcohol biosensor for 30 days and report alcohol use using a ecological momentary assessment (EMA) app. A subset of the sample will be micro-randomized to test two engagement strategies--reciprocity and personalized feedback via the eWrapper app to promote their engagement with the biosensor.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesUnited States
CollaboratorsUniversity of Florida, University of Michigan, National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 24, 2022
Enrollment StartFeb 1, 2023
Primary CompletionFeb 12, 2025
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.0 years ago

Interventions

eWrapper-Engagement strategies to facilitate alcohol biosensor wearingbehavioral

The eWrapper app includes two engagement strategies (reciprocity and personalized feedback) and implements a micro-randomized trial (MRT) design to test whether the strategies work.